ElectroCore Inc
Research ElectroCore Inc (ECOR) on Bullrun: market cap USD 85.24M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerECOR
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 85.24M
- Financial periodQ2 2026
- RevenueUSD 9.45M
- Net income-USD 3.06M
- Free cash flow-USD 3.52M
- Gross margin86.5%
Valuation Snapshot
latest market cap is USD 85.24M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 32.03M | -USD 13.97M | -USD 8.25M | 86.8% | -1.65 | USD 7.04M | USD 6.61M | -USD 1.71M |
| FY2024 | USD 25.18M | -USD 11.89M | -USD 6.95M | 85.0% | -1.59 | USD 3.70M | USD 4.14M | USD 7.54M |
| FY2023 | USD 16.03M | -USD 18.83M | -USD 14.87M | 82.5% | -3.42 | USD 10.33M | USD 626.00K | USD 7.44M |
| FY2022 | USD 8.59M | -USD 22.16M | n/a | 81.2% | -4.69 | USD 17.71M | USD 732.00K | USD 17.09M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 85.24M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 35.94M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 107.81M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 35.71M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 18.32M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 41.20M | n/a | n/a | n/a |
About ElectroCore Inc
electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is ElectroCore Inc's market cap?
ElectroCore Inc's market capitalization is USD 85.24M.
What does ElectroCore Inc do?
electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.